Cargando…

SARS-CoV-2 Molecular Diagnostics in China

The COVID-19 pandemic remains a significant problem involving health systems worldwide. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. rRT-PCR is considered the gold standard; however, as it required skilled personnel and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yanjun, Sun, Ziyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894802/
https://www.ncbi.nlm.nih.gov/pubmed/35636821
http://dx.doi.org/10.1016/j.cll.2022.03.003
_version_ 1784662763042242560
author Lu, Yanjun
Sun, Ziyong
author_facet Lu, Yanjun
Sun, Ziyong
author_sort Lu, Yanjun
collection PubMed
description The COVID-19 pandemic remains a significant problem involving health systems worldwide. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. rRT-PCR is considered the gold standard; however, as it required skilled personnel and special equipment, rapid antigen tests have been developed and used as first-line screening. The serologic testing of antibodies can also be used to enhance the detection sensitivity and accuracy, which are used to assess the overall infection rate. This review summarizes the molecular techniques and serologic assays widely used in China and discusses the advantages and disadvantages of these techniques.
format Online
Article
Text
id pubmed-8894802
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88948022022-03-04 SARS-CoV-2 Molecular Diagnostics in China Lu, Yanjun Sun, Ziyong Clin Lab Med Article The COVID-19 pandemic remains a significant problem involving health systems worldwide. Several diagnostic methods are reported for detecting the coronavirus in clinical, research, and public health laboratories. rRT-PCR is considered the gold standard; however, as it required skilled personnel and special equipment, rapid antigen tests have been developed and used as first-line screening. The serologic testing of antibodies can also be used to enhance the detection sensitivity and accuracy, which are used to assess the overall infection rate. This review summarizes the molecular techniques and serologic assays widely used in China and discusses the advantages and disadvantages of these techniques. Elsevier Inc. 2022-06 2022-03-04 /pmc/articles/PMC8894802/ /pubmed/35636821 http://dx.doi.org/10.1016/j.cll.2022.03.003 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lu, Yanjun
Sun, Ziyong
SARS-CoV-2 Molecular Diagnostics in China
title SARS-CoV-2 Molecular Diagnostics in China
title_full SARS-CoV-2 Molecular Diagnostics in China
title_fullStr SARS-CoV-2 Molecular Diagnostics in China
title_full_unstemmed SARS-CoV-2 Molecular Diagnostics in China
title_short SARS-CoV-2 Molecular Diagnostics in China
title_sort sars-cov-2 molecular diagnostics in china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894802/
https://www.ncbi.nlm.nih.gov/pubmed/35636821
http://dx.doi.org/10.1016/j.cll.2022.03.003
work_keys_str_mv AT luyanjun sarscov2moleculardiagnosticsinchina
AT sunziyong sarscov2moleculardiagnosticsinchina